Gene expression profiling of CD8+ T cells from CLL patients has uncovered disruptions in key cellular processes such as actin polymerization, vesicle trafficking, and cytotoxicity signaling pathways (Görgün et al., 2005), reinforcing the concept of T-cell dysfunction in CLL. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.